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Background: It is unclear what factors clinicians consider when deciding about
endovascular thrombectomy (EVT) in acute ischemic stroke patients with a pre-existing
disability. We aimed to explore international practice patterns and preferences for EVT in
patients with a pre-stroke disability, defined as a modified Rankin score (mRS) ≥ 2.
Methods: Electronic survey link was sent to principal investigators of five major EVT
trials and members of a professional interventional neurology society.
Results: Of the 81 survey-responding clinicians, 57% were neuro-interventionalists and
33% were non-interventional stroke clinicians. Overall, 64.2% would never or almost
never consider EVT for a patient with pre-stroke mRS of 4-5, and 49.3% would always
or almost always offer EVT for a patient with pre-stroke mRS 2-3. Perceived benefit of
EVT (89%) and severity of baseline disability (83.5%) were identified as the most important
clinician-level and patient-level factors that influence EVT decisions in these patients.
Conclusion: In this survey of 80 respondents, we found that EVT practice for patients
with pre-stroke disability across the world is heterogenous and depends upon patient
characteristics. Individual clinician opinions substantially alter EVT decisions in pre-stroke
disabled patients.
Keywords: ischemic stroke, endovascular treatment, acute stroke, treatment, survey, disability

INTRODUCTION
The American Heart Association/American Stroke Association national practice guidelines for
management of acute ischemic stroke only recommend offering endovascular thrombectomy
(EVT) to patients with an acute ischemic stroke involving a large anterior cerebral vessel
occlusion without a pre-stroke disability, defined as pre-stroke modified Rankin Score (mRS)
of 0 or 1 (1). However, about a third of acute ischemic stroke patients are disabled at
pre-stroke baseline (2, 3). Small, observational studies have shown that: (1) almost one
in three patients undergoing EVT in routine clinical practice has a baseline pre-stroke
disability, and (2) when treated with EVT, patients with pre-stroke disability have similar
odds of retaining their baseline function as do patients without pre-stroke disability (4–6).
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To better understand current EVT care approaches for prestroke disabled patients without guideline recommendations,
it is important to study individual clinician and institutional
level practice and preferences regarding EVT in patients with
pre-stroke disability. We conducted a survey of international
experts in EVT and practitioners of interventional neurology
to understand how EVT decisions are made in routine clinical
practice for patients with pre-stroke disability. Here, we describe
factors influencing physician decisions when considering EVT
for patients with pre-existing disability, including the impact of
level and type of disability, additional patient characteristics, and
institutional protocols informing EVT treatment decisions.

TABLE 1 | Demographics of survey respondents.
n = 81 (%)
Male
<5 years

12 (14.8)

>10 years

47 (58.0)

5-10 years

22 (27.2)

Primary specialty
Emergency medicine

1 (1.2)

General neurology

MATERIALS AND METHODS

1 (1.2)

Interventional neuro-radiology

10 (12.3)

Interventional vascular neurology

36 (44.4)

Neuro hospitalist

3 (3.7)

Neurocritical care

Survey Design

1 (1.2)

Non-interventional vascular neurology

A 20-item survey was developed by the authors based on factors
most frequently cited in prior literature as influential in the
EVT decision-making process. A pilot version was completed
by 24 physicians at two institutions. Feedback from respondents
was used to improve survey readability and accuracy. The
final survey questionnaire in its entirety is provided in the
Supplementary Material. The survey had inbuilt logic where
participants could proceed with answering follow-up questions
relevant to and dependent on their answers to a prior question.
Participants were first asked if they would ever consider EVT
in patients with pre-stroke mRS 2 and pre-stroke mRS 3. If
they answered no, their responses for pre-stroke mRS 4-5 were
automatically also handled as no. If they answered yes to either,
they were asked to further rate the degree of their likelihood, on
a 6-level Likert scale, of offering EVT to patients with pre-stroke
mRS of 2-3 and patients with pre-stroke mRS of 4-5. Similarly,
specifics of institutional patient selection protocols were only
asked if a participant responded yes to having an institutional
protocol on EVT practice. In addition, respondents were asked
to identify among 14 general, patient-specific, and stroke-specific
features those that were most important to their decision-making
regarding offering EVT to individual patients with pre-stroke
disability. As both benefits or harms of EVT are yet unknown
for patients with a pre-stroke disability, we refer to each as
“perceived” by the treating clinician.

27 (33.3)

Other

1 (1.2)

Vascular neurosurgery

1 (1.2)

Academic rank
Assistant Professor

15 (18.5)

Associate Professor

22 (27.2)

Fellow

10 (12.3)

Instructor

1 (1.2)

Other

10 (12.3)

Professor

23 (28.4)

Proportion of time dedicated to caring for stroke patients
0-10%

2 (2.5)

11-50%

21 (25.9)

51-99%

46 (56.8)

100%

12 (14.8)

Analysis
Survey responses were de-identified. Survey respondent
characteristics
were
characterized
using
frequencies
(numerator/denominator) for each response option. Ordinal
three-level frequency distributions of physician likelihood of
pursuing EVT [(1) always/almost always, (2) often/sometimes,
(3) almost never, never of pursuing EVT] were calculated
separately for the two scenarios of patients with pre-stroke
disability of mRS 2-3 and patients with pre-stroke disability of 4-5
and separately for non-interventionalists and interventionalists.
Frequencies of physician selection of multiple-choices among 14
response options for general, patient-specific, and stroke-specific
features most important to EVT decision-making in patients
with pre-stroke disability were calculated and reported in rank
order from most to least frequent.

Survey Distribution
Invitations to complete the final survey were emailed to all
author-investigators of the first five international pivotal EVT
trials of stent retrievers and to members of the Society of Vascular
and Interventional Neurology (SVIN) (7–11). For the authors
of the international trials, two follow-up emails were sent if
initial emails did not elicit a response. For SVIN members, no
follow-up emails were sent as per Society policy. Study data were
collected from January 8, 2020 to January 9, 2020 and managed
using REDCap (Research Electronic Data Capture) electronic
data capture tools hosted at Vanderbilt University Medical Center
(12, 13). Survey responses were de-identified and analyzed across
three major domains- current perspectives on how pre-stroke
disability level and type, patient characteristics, and institutional
factors impact decision to treat.
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71 (87.7)

Years in practice

RESULTS
Respondent Characteristics
Completed survey responses were received from a total of 81
physician-experts, including 33 from among the international
EVT trial authors and 48 from among the SVIN society
members. The response rate among the international EVT trial
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FIGURE 1 | Physician likelihood of considering EVT for patients with pre-stroke disability of mRS 2-3 vs. 4-5.

authors total was 33/119 (28%). The denominator for the SVIN
survey recipients was unavailable due to use of email listserv
technical constraints.
The characteristics of survey physician respondents is
shown in Table 1. Among the 81 respondents, the majority
identified as male (71/81, 87.7%). The most common
specialties were interventional vascular neurology and noninterventional vascular neurology, followed by interventional
neuroradiologists, with smaller proportions of neurohospitalists,
vascular neurosurgeons, general neurologists, and emergency
medicine physicians. The majority of respondents had practice
experience of more than 10 years duration, and a little over
a quarter between 5 and 10 years, with one-sixth having <5
years. The most common academic ranks were Full Professor
and Associate Professor, followed by Assistant Professor, with
Fellows accounting for just over 1 in 10. Overall, proportion
of clinical time dedicated to stroke care was over half in 71.6%
and between 10 and 50% in another 25.9%. No two respondents
were from the same institution. There were no missing data for
this analysis.

TABLE 2 | Frequency of EVT for mRS 2-3 and mRS 4-5 by subspecialty.
Noninterventionalists
(n = 34)

Always

19%

12%

Almost always

32%

36%

Often

23%

15%

Sometimes

26%

29%

Almost never

0%

0%

Never

0%

3%

Always

0%

0%

Almost always

0%

3%

Often

0%

0%

Pre-stroke mRS 2-3

Pre-stroke mRS 4-5

Perspectives on Pre-stroke Disability and
Treatment

Sometimes

38%

24%

Almost never

43%

39%

Never

19%

32%

1.2% (1/81) would always or almost always offer EVT; 34.6%
(28/81) would often or sometimes offer EVT; and 64.2% (52/81)
would almost never or never offer EVT. Table 2 shows the
degree of physician likelihood of offering EVT separately for
neurointerventionalists and non-interventionalists. Overall,
neurointerventionalists were mildly more likely than noninterventionalists to offer EVT to both patients with pre-stroke
disability of mRS 2-3 and patients with pre-stroke disability of
mRS 4-5. Supplementary Table 1 provides a detailed breakdown
by subspecialty of the likelihood with which respondents
indicated they would consider EVT for mRS 2-3 and EVT for
mRS 4-5.

The frequency with which physicians indicated they would ever
consider EVT for an otherwise eligible patient was: 97.5% for
pre-stroke mRS 2; 79% for mRS 3; and 74% for mRS 4-5.
The degrees of physician likelihood of considering,
performing, or offering EVT for patients with pre-stroke
disability of mRS 2-3 and patients with pre-stroke disability
of 4-5 are shown in Figure 1. For patients with mRS 2-3, a
total of 49.3% (40/81) would always or almost always offer
EVT; 47.0% (38/81) would often or sometimes offer EVT;
and 3.8% (3/81) would almost never or never offer EVT. In
contrast, for patients with pre-stroke mRS of 4 or 5, a total of
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Neurointerventionalists
(n = 47)

Frequency of EVT
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FIGURE 2 | Factors affecting EVT decision-making.

most indicated that protocols did not take a stand on how to
treat patients with pre-existing disability and left the decision
up to individual physicians (36/65, 55%). Only five institutions
had explicit guidance on how to treat patients with preexisting disability with three recommending to never treat
and two recommending to always treat patients with preexisting disability. The remaining 24 organizations providing any
direction advised that patients with pre-stroke disability were
sometimes candidates for EVT.

Most respondents considered the complication risk (60/79,
76%) and the likelihood of recanalization (73/79, 92%) to be
the same between patients with vs. without pre-stroke disability.
However, most physicians thought patients with pre-existing
disability had a lower rate of return to baseline disability
(53/79, 67%).
Respondents were asked to identify among 14 general,
patient-specific, and stroke-specific features those that were most
important to their decision-making regarding offering EVT to
individual patients with pre-stroke disability. Among the 79
respondents who indicated they would ever offer EVT to a patient
with pre-stroke mRS 2-5, Figure 2 shows the frequency with
which they identified 14 general, patient-specific, and stroke
specific features as most important to their decision-making
regarding offering EVT to individual patients with pre-stroke
disability. Perceived benefit was the factor that physicians took
into consideration most often when deciding whether to offer
an EVT to a patient with pre-existing disability (70/79, 89%).
Among patient-related factors that influenced decision making,
66 physicians chose severity of disability (83.5%), 46 chose
baseline societal productivity (58.2%), and 31 chose age (39%) as
important factors. Only 22 (28%) physicians chose either societal
support and 22 (28%) permanence of disability as important
factors. Among stroke-specific characteristics, volume of infarct
was the factor that physicians most often cited as influential
(61/79, 77%).

DISCUSSION
We observed considerable individual clinician and institutionallevel heterogeneity in EVT practice among acute ischemic
stroke patients with a pre-existing disability in this survey of
80 respondents. Disposition to pursue treatment was strongly
influenced by the level of patients’ pre-existing disability.
While nearly half of the survey respondents noted that they
would always or almost always treat patients with mild-tomoderate pre-existing disability, a preponderance of respondents
noted they would almost never or never do so for patients
with severe disability. In addition to the wide variation in
overall propensity to treat, physicians varied substantially when
identifying which general, patient-specific, and stroke-specific
characteristics were important to them when making treatment
decisions in individual patients with pre-stroke disability.
The current AHA/ASA guidelines only recommend offering
EVT to acute ischemic stroke patients who do not have
a pre-existing disability (1). This guideline is based on the
completed randomized trials assessing EVT efficacy, which
excluded patients with a pre-stroke mRS 2-5 (7–11). Patients

Institutional Practices
A substantial majority of physicians (65/81, 80%) responded
that their institution had general guidance on how to select
patients for EVT. Of those reporting institutional guidance,
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that the views of non-respondents would have differed from those
of respondents. The strengths of our study include responses
from physicians in nine different subspecialties with a good mix
of practice experience, academic rank, and geographic diversity.

who are disabled at pre-stroke baseline are typically excluded
from initial pivotal acute stroke clinical trials because the
trials measure success of acute stroke therapies by the extent
to which they reduce all-cause disability after stroke. Prestroke disabled patients are less informative for this outcome
as their pre-stroke disability constrains the degree to which
the acute stroke treatment can affect final all-cause disability.
However, because a sizeable proportion of acute ischemic
stroke patients are disabled prior to their index stroke, a
detailed understanding of pre-stroke disability sources, prestroke disability functional profiles, ideal outcome measures, and
presence and magnitude of treatment effects of acute stroke
treatments such as EVT are urgently needed to ensure inclusive
design of future acute stroke research and rapid translation of
therapeutic advances into care of disabled patients. A detailed
understanding of the current landscape of the EVT practice
in this population could significantly aid such future, large,
multicenter, prospective studies.
The present study not only highlights heterogeneity in
EVT practice among patients with pre-stroke disability, but
offers some insights into factors influencing individual clinician
reasoning in this practice. While most of the survey respondents
believed that the complication risks and success of recanalization
were the same for patients with pre-stroke disability as those
without pre-stroke disability, the majority also believed that
patients with pre-stroke disability would be less likely to return
to their baseline disability. Almost 90% of physicians considered
their own valuation, or perception, of benefit to patient as a major
factor in deciding whether to offer EVT to patients with disability.
It is important to note that, in the absence of comparative data on
benefits and risks of EVT compared with medical management,
clinician perception is based on physiologic reasoning (as noted
by majority of the physicians choosing baseline volume of infarct
and Alberta Stroke Program Early CT, ASPECT, score as the
most important stroke characteristic for offering EVT) and
personal experience, rather than definitive randomized clinical
trial evidence. Accordingly, the findings of this study reflect
the current range of opinion and intuition among individual
clinicians making EVT decisions for pre-stroke disabled patients
and underscore the need for more reliable, formal evidence.
Importantly, large variation in institutional guidance for EVT
in patients with pre-existing disability is highlighted in our study.
The majority of institutional protocols remain silent on EVT
specifically pertaining to pre-stroke disable patients and leave
clinical decision making up to individual clinicians. Of the 6% of
institutions with strict guidance on offering EVT to patients with
existing disability, half recommended to always offer and half
recommended to never offer EVT to pre-stroke disabled patients,
highlighting inter-institutional heterogeneity in practice.
Our study has several limitations. First, respondents of our
survey were drawn from lead investigators in international EVT
trials and members of a US professional society largely populated
by interventional neurologists. Therefore, our results may not be
generalizable to the entire population of physicians that perform
endovascular interventions for acute ischemic stroke. Second, the
response rate to survey invitations was moderate and it is possible
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CONCLUSIONS
In this International survey of 80 respondents, we found
considerable individual clinician and institutional-level
heterogeneity in EVT practice among acute ischemic stroke
patients with a pre-existing disability. Likelihood to offer EVT
differed according to baseline disability as well as patient and
stroke characteristics. Further research into effects of EVT among
patients with a pre-stroke disability is warranted. Such research
should utilize novel study methodologies and outcome measures
to overcome challenges of studying this patient population.
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